Novo Nordisk Inks A $2.1 Billion Deal To Develop Next Generation Obesity Pills

The Danish drugmaker is collaborating with Vivtex, cofounded by billionaire Robert Langer, to quickly iterate oral versions of successors to Ozempic and Wegovy.

Continue Reading

News Source: www.forbes.com